{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:35:26Z","timestamp":1772120126904,"version":"3.50.1"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Autoimmune diseases are frequently associated with an increased risk of venous thromboembolism (VTE). However, the relationship between ankylosing spondylitis (AS) and VTE remains unclear. This meta-analysis was conducted to evaluate the association between AS and VTE risk, with the aim of providing evidence-based insights to guide clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>We searched PubMed, Embase, the Cochrane Library, and Web of Science for studies published from database inception until June 2025 that compared VTE risk in patients with AS. Two researchers independently screened the literature based on predefined inclusion and exclusion criteria. The risk of bias in included studies was assessed using the Risk of Bias in Non-randomized Studies of Interventions (ROBINS-I) tool. Adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) were pooled to estimate effect sizes. Subgroup analyses were performed according to the type of thrombosis event. Sensitivity analysis was conducted by sequentially excluding each study. Publication bias was preliminarily assessed using funnel plots. The overall quality of evidence was evaluated using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework. All analyses were performed using RevMan 5.3 software. The study protocol was registered retrospectively in PROSPERO (Registration number: CRD420251107387).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Six studies involving 601,585 patients were included. The meta-analysis indicated that AS was associated with a significantly higher risk of VTE (HR = 1.47, 95%CI(1.22,1.77), P &amp;lt; 0.0001; evidence quality: Very low). Subgroup analyses revealed that AS was significantly associated with an increased risk of overall VTE, deep vein thrombosis (DVT), and pulmonary embolism (PE) (VTE: HR = 1.57, 95%CI(1.26, 1.96), P &amp;lt; 0.0001; DVT: HR = 1.62, 95%CI(1.16, 2.26), P = 0.005; PE: HR = 1.24, 95%CI(1.06, 1.45), P = 0.008).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Current evidence indicates that AS may elevate the risk of VTE. Further mechanistic studies are needed to better interpret these findings derived from observational data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/<\/jats:ext-link>\n                      , identifier CRD420251107387.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1670965","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T06:30:04Z","timestamp":1765261804000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["The association between ankylosing spondylitis and the risk of venous thromboembolism: a meta-analysis"],"prefix":"10.3389","volume":"16","author":[{"given":"Quan","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruihan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.4252\/wjsc.v17.i5.106934","article-title":"Aberrant bone formation and dysregulated bone homeostasis in ankylosing spondylitis","volume":"17","author":"Lee","year":"2025","journal-title":"World J Stem Cells"},{"key":"B2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/ard-2022-223296","article-title":"Asas-eular recommendations for the management of axial spondyloarthritis: 2022 update","volume":"82","author":"Ramiro","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket387","article-title":"Global prevalence of ankylosing spondylitis","volume":"53","author":"Dean","year":"2014","journal-title":"Rheumatol (Oxford)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e003504","DOI":"10.1136\/rmdopen-2023-003504","article-title":"International map of axial spondyloarthritis (Imas): results from the perspective of 5557 patients from 27 countries around the globe","volume":"10","author":"Garrido-Cumbrera","year":"2024","journal-title":"RMD Open"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-9-1","article-title":"Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study","volume":"9","author":"Ramagopalan","year":"2011","journal-title":"BMC Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2012.04666.x","article-title":"Autoimmune skin and connective tissue diseases and risk of venous thromboembolism: A population-based case-control study","volume":"10","author":"Johannesdottir","year":"2012","journal-title":"J Thromb Haemost"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(11)61306-8","article-title":"Risk of pulmonary embolism in patients with autoimmune disorders: A nationwide follow-up study from Sweden","volume":"379","author":"Z\u00f6ller","year":"2012","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13075-017-1315-z","article-title":"Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study","volume":"19","author":"Bengtsson","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214388","article-title":"Risk of venous thromboembolism in ankylosing spondylitis: A general population-based study","volume":"78","author":"Avi\u00f1a-Zubieta","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.3390\/jcm13102790","article-title":"Increased risk for pulmonary embolism among patients with ankylosing spondylitis-results from a large database analysis","volume":"13","author":"Gendelman","year":"2024","journal-title":"J Clin Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvn.2015.02.001","article-title":"Venous thromboembolism: an overview","volume":"33","author":"Bruni-Fitzgerald","year":"2015","journal-title":"J Vasc Nurs"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11239-015-1311-6","article-title":"The epidemiology of venous thromboembolism","volume":"41","author":"Heit","year":"2016","journal-title":"J Thromb thrombolysis"},{"key":"B13","article-title":"Venous thromboembolism in adult hospitalizations - United States, 2007-2009","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12519","article-title":"Incidence of hospital readmission in patients diagnosed with dvt and pe: clinical burden of recurrent events","volume":"69","author":"Nutescu","year":"2015","journal-title":"Int J Clin Pract"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2018.04.021","article-title":"Secular trends and etiologies of venous thromboembolism in chinese from 2004 to 2016","volume":"166","author":"Huang","year":"2018","journal-title":"Thromb Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2018.10.040","article-title":"Trends in hospitalization and in-hospital mortality from vte, 2007 to 2016, in China","volume":"155","author":"Zhang","year":"2019","journal-title":"Chest"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07323.x","article-title":"Virchow and his triad: A question of attribution","volume":"143","author":"Bagot","year":"2008","journal-title":"Br J haematology"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1177\/1358863x15573838","article-title":"Venous thromboembolism in systemic autoimmune diseases: A narrative review with emphasis on primary systemic vasculitides","volume":"20","author":"Tamaki","year":"2015","journal-title":"Vasc Med"},{"key":"B19","article-title":"Autoimmune diseases and venous thromboembolism: A review of the literature","volume":"2","author":"Z\u00f6ller","year":"2012","journal-title":"Am J Cardiovasc Dis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103447","article-title":"Risk of venous thromboembolism in autoimmune diseases: A comprehensive review","volume":"22","author":"Menichelli","year":"2023","journal-title":"Autoimmun Rev"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.clinthera.2021.06.008","article-title":"Risk of thromboembolic events and associated risk factors, including treatments, in patients with immune-mediated diseases","volume":"43","author":"Setyawan","year":"2021","journal-title":"Clin Ther"},{"key":"B22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/HM9.0000000000000029","article-title":"Acupuncture and Moxibustion Treating Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Systematic Review and Network Meta-Analysis","volume":"2","author":"Chen","year":"2022","journal-title":"Acupuncture Herbal Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The prisma 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clinical Res ed)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/HM9.0000000000000172","article-title":"Effectiveness of acupuncture in managing aromatase inhibitor-related arthralgia in breast cancer: A systematic review and meta-analysis","volume":"5","author":"Zhu","year":"2025","journal-title":"Acupuncture Herbal Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","article-title":"Robins-I: A tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"Bmj"},{"key":"B26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/bor.0000000000000670","article-title":"Venous involvement in inflammatory disorders","volume":"32","author":"Seyahi","year":"2020","journal-title":"Curr Opin Rheumatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4103\/0970-2113.192862","article-title":"Ankylosing spondylitis and risk of venous thromboembolism: A systematic review and meta-analysis","volume":"33","author":"Ungprasert","year":"2016","journal-title":"Lung India"},{"key":"B28","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3390\/jcm13020362","article-title":"A comprehensive review of risk factors and thrombophilia evaluation in venous thromboembolism","volume":"13","author":"Dicks","year":"2024","journal-title":"J Clin Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1024\/0301-1526\/a001145","article-title":"Epidemiology of deep vein thrombosis","volume":"53","author":"Wolf","year":"2024","journal-title":"Vasa"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8491717","article-title":"Coexistence of rheumatoid arthritis, systemic lupus erythematosus, sjogren syndrome, antiphospholipid syndrome, and ankylosing spondylitis","volume":"2021","author":"Khasru","year":"2021","journal-title":"Case Rep Rheumatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-010-1439-9","article-title":"Coexisting beh\u00e7et\u2019s disease and ankylosing spondylitis presented with deep venous thrombosis: A case report and review of the literature","volume":"32","author":"Yoo","year":"2012","journal-title":"Rheumatol Int"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i18.2162","article-title":"Inflammatory bowel diseases and spondyloarthropathies: from pathogenesis to treatment","volume":"25","author":"Fragoulis","year":"2019","journal-title":"World J Gastroenterol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s40744-022-00513-1","article-title":"Systematic literature review and meta-analysis of venous thromboembolism events in systemic lupus erythematosus","volume":"10","author":"Bello","year":"2023","journal-title":"Rheumatol Ther"},{"key":"B34","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/j.medcli.2024.02.010","article-title":"Thrombotic antiphospholipid syndrome: from guidelines to clinical management","author":"Paredes-Ruiz","year":"2024","journal-title":"Med Clin (Barc)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.07.042","article-title":"Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management","volume":"161","author":"Rogler","year":"2021","journal-title":"Gastroenterology"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(23)02629-6","article-title":"Beh\u00e7et\u2019s syndrome","volume":"403","author":"Emmi","year":"2024","journal-title":"Lancet"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcma.2012.05.006","article-title":"Association of serum interleukin-17 and interleukin-23 levels with disease activity in chinese patients with ankylosing spondylitis","volume":"75","author":"Chen","year":"2012","journal-title":"J Chin Med Assoc"},{"key":"B38","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11926-019-0856-3","article-title":"The pathogenesis of ankylosing spondylitis: an update","volume":"21","author":"Pedersen","year":"2019","journal-title":"Curr Rheumatol Rep"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1433858","article-title":"Editorial: inflammation, the link between venous and arterial thrombosis","volume":"11","author":"\u017digon","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-11-882993","article-title":"Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms","volume":"133","author":"Jackson","year":"2019","journal-title":"Blood"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2018.04.010","article-title":"Immune factors in deep vein thrombosis initiation","volume":"39","author":"Budnik","year":"2018","journal-title":"Trends Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023022522","article-title":"Hot under the clot: venous thrombogenesis is an inflammatory process","volume":"144","author":"Rayes","year":"2024","journal-title":"Blood"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2018.08.022","article-title":"Nlrp3 inflammasomes and nlrp3 inflammasome-derived proinflammatory cytokines in peripheral blood mononuclear cells of patients with ankylosing spondylitis","volume":"486","author":"Kim","year":"2018","journal-title":"Clin Chim Acta"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.210131","article-title":"Risk of venous thromboembolism in ankylosing spondylitis and rheumatoid arthritis: genetic aspects","volume":"48","author":"Goulielmos","year":"2021","journal-title":"J Rheumatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1670965\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T06:30:05Z","timestamp":1765261805000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1670965\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":44,"alternative-id":["10.3389\/fimmu.2025.1670965"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1670965","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"article-number":"1670965"}}